Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ymgme.2020.04.002 http://scihub22266oqcxt.onion/10.1016/j.ymgme.2020.04.002 32386848!7189198!32386848     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32386848&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Mol+Genet+Metab 2020 ; 130 (3): 170-171 Nephropedia Template TP {{tp|p=32386848|t=2020. Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience |pdf=|usr=}}{{32386848}} gab.com Text Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience JO: Mol Genet Metab http://www.kidney.de/pget.php?&tw=1&pmid=32386848 #FOAvip The direct and indirect effects of Coronavirus Disease-19 (COVID-19) pandemic, on Italian patients with lysosomal storage disorders receiving therapy, were analyzed by a phone questionnaire. No proved COVID-19 emerged among 102 interviewed. No problems were reported by patients receiving oral treatments. Forty-nine% of patients receiving enzyme replacement therapy in hospitals experienced disruptions, versus 6% of those home-treated. The main reasons of missed infusions were fear of infection (62.9%) and re-organization of the infusion centers (37%). Twit Text FOAVip Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience ????Mol Genet Metab http://www.kidney.de/pget.php?&tw=1&pmid=32386848 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32386848 #FOAvip English Wikipedia <ref>{{Cite pmid|32386848}}</ref> Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience #MMPMID32386848 Sechi A; Macor D; Valent S; Da Riol RM; Zanatta M; Spinelli A; Bianchi K; Bertossi N; Dardis A; Valent F; Scarpa M Mol Genet Metab 2020[Jul]; 130 (3): 170-171 PMID32386848show ga The direct and indirect effects of Coronavirus Disease-19 (COVID-19) pandemic, on Italian patients with lysosomal storage disorders receiving therapy, were analyzed by a phone questionnaire. No proved COVID-19 emerged among 102 interviewed. No problems were reported by patients receiving oral treatments. Forty-nine% of patients receiving enzyme replacement therapy in hospitals experienced disruptions, versus 6% of those home-treated. The main reasons of missed infusions were fear of infection (62.9%) and re-organization of the infusion centers (37%). |Adult[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*epidemiology/psychology/therapy[MESH] |Enzyme Replacement Therapy[MESH] |Fear[MESH] |Female[MESH] |Humans[MESH] |Italy/epidemiology[MESH] |Lysosomal Storage Diseases/complications/*therapy[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Patient Acceptance of Health Care[MESH] |Patient Care Management[MESH] |Pneumonia, Viral/complications/*epidemiology/psychology/therapy[MESH] |Surveys and Questionnaires[MESH]Impact of COVID-19 related healthcare crisis on treatments for patient(epmc).pdf DeepDyve Pubget Overpricing